p30
Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India Varun Dhir, Shung Ming Chiu, Rajiva Gupta, Shery Susan Phillip, Padmanabha Shenoy, Bharati Taksande, Dhiren Rawal, Kuldeep Kumar, Gargi Singh, Sandeep Kumar, Shahzeene Dhuria, Anuroopa Manovihar, Apoorva Bhagat, Chaitanya Soni, Sanjay Jain, Vineeta Shobha Download
